文献速递肝病消化道出血

小直径经颈静脉肝内门体分流术联合静脉曲张栓塞治疗胃静脉曲张:多中心队列研究

Small Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Embolization for Gastric Varices: A Multicenter Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-05-16

这项回顾性多中心队列研究纳入629例接受8毫米经颈静脉肝内门体分流术(TIPS)的胃静脉曲张患者,评估联合栓塞是否降低再出血。全队列中联合栓塞较单纯TIPS降低再出血(6.2% vs 13.6%,P=.005)和肝性脑病(31.0% vs 39.4%,P=.02),死亡率无显著差异;GOV2和IGV1患者获益,GOV1患者无获益。

要点

  • 8毫米TIPS联合栓塞较单纯TIPS降低全队列再出血(6.2% vs 13.6%)和肝性脑病(31.0% vs 39.4%)。
  • GOV2和IGV1患者联合栓塞降低再出血和肝性脑病,GOV1患者无显著获益。
  • 全队列死亡率联合栓塞组12.0% vs 单纯TIPS组9.7%,无显著差异(P=.42)。

核心结论

  • 与单纯TIPS相比,8毫米TIPS联合静脉曲张栓塞可降低GOV2和IGV1患者的再出血和肝性脑病。
  • 这些发现提示GOV2和IGV1而非GOV1患者可能从TIPS联合栓塞中获益。

研究设计与样本

  • 回顾性多中心队列研究,纳入7个医学中心接受8毫米TIPS治疗胃静脉曲张的629例患者。
  • 主要终点为全因再出血,次要终点包括显性肝性脑病(OHE)和全因死亡。

主要发现

  • 全队列中联合栓塞组再出血6.2% vs 单纯TIPS组13.6%(P=.005),OHE 31.0% vs 39.4%(P=.02)。
  • 全队列死亡率联合栓塞组12.0% vs 单纯TIPS组9.7%,无显著差异(P=.42)。
  • GOV2患者联合栓塞组再出血7.8% vs 25.1%(P=.01),OHE 31.8% vs 51.5%(P=.008)。
  • IGV1患者联合栓塞组再出血5.6% vs 30.8%(P=.03),OHE 11.6% vs 38.5%(P=.04)。
  • GOV1患者联合栓塞组再出血5.9% vs 8.7%(P=.37),OHE 33.1% vs 35.3%(P=.60),均无显著差异。

关键数值与推荐

  • 629例中GOV1 429例(68.2%),GOV2 145例(23.1%),IGV1 55例(8.7%)。

临床怎么用

  • 原文结论提示GOV2和IGV1而非GOV1患者可能从8毫米TIPS联合栓塞中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The effect of transjugular intrahepatic portosystemic shunt (TIPS) plus variceal embolization for treating gastric varices (GVs) remains controversial. This nationwide multicenter cohort study aimed to evaluate whether adding variceal embolization to a small diameter (8-mm) TIPS could reduce the rebleeding incidence in patients with different types of GVs. METHODS: This retrospective cohort study involved 629 patients who underwent 8-mm TIPS for gastric varices at 7 medical centers. The primary endpoint was all-cause rebleeding, and the secondary endpoints included overt hepatic encephalopathy (OHE) and all-cause mortality. RESULTS: A total of 629 patients were included. Among them, 429 (68.2%) had gastroesophageal varices type 1 (GOV1), 145 (23.1%) had gastroesophageal varices type 2 (GOV2), and 55 (8.7%) had isolated gastric varices type 1 (IGV1). In the entire cohort, adjunctive embolization reduced rebleeding (6.2% vs 13.6%; P = .005) and OHE (31.0% vs 39.4%; P = .02) compared with TIPS alone. However, no significant differences were found in mortality (12.0% vs 9.7%; P = .42). In patients with GOV2 and IGV1, TIPS plus variceal embolization reduced both rebleeding (GOV2: 7.8% vs 25.1%; P = .01; IGV1: 5.6% vs 30.8%; P = .03) and OHE (GOV2: 31.8% vs 51.5%; P = .008; IGV1: 11.6% vs 38.5%; P = .04). However, in patients with GOV1, adjunctive embolization did not reduce rebleeding (5.9% vs 8.7%; P = .37) or OHE (33.1% vs 35.3%; P = .60). CONCLUSIONS: Compared with TIPS alone, 8-mm TIPS plus variceal embolization reduced rebleeding and OHE in patients with GOV2 and IGV1. These findings suggest that patients with GOV2 and IGV1, rather than GOV1, could benefit from embolization with TIPS.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Xia Y, Tie J, Wang G, et al. Small Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Embolization for Gastric Varices: A Multicenter Cohort Study. Clin Gastroenterol Hepatol. 2024. PMID: 38759828. doi:10.1016/j.cgh.2024.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。